期刊
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
卷 195, 期 5, 页码 1398-1403出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2006.02.049
关键词
preeclampsia; hypertension; heart; magnesium; rats
资金
- NHLBI NIH HHS [1 R15 HL073777-01] Funding Source: Medline
Objective: We hypothesized that cardiac function would be reduced in a pregnant rat model of preeclampsia induced by L-NAME, a NOS inhibitor, and be reversed with magnesium sulfate prophylaxis. Study design: Female Sprague-Dawley rats were bred in-house. On gestational day 17, rats were anesthetized and osmotic minipunips were implanted to continuously deliver saline, L-NAME, or L-NAME and MgSO4. On gestational day 21, hearts were isolated and perfused in the working mode using Krebs Henseleit buffer. Results: Pregnant rats treated with L-NAME displayed significant hypertension compared to the saline-treated controls (P < 0.05). Moreover, cardiac output and cardiac work were significantly reduced in the L-NAME-treated rats compared to controls (P < 0.05). In the L-NAME-treated rats given MgSO4, cardiac function remained normal. Conclusion: Cardiac function is depressed in an animal model of precclampsia induced by L-NAME infusion. MgSO4 prevented the reduction in cardiac function and is clearly beneficial in preserving normal heart function in preeclampsia. (c) 2006 Mosby, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据